Dashboard
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
With a fall in Net Sales of -16.36%, the company declared Very Negative results in Sep 25
With ROCE of 1.8, it has a Very Expensive valuation with a 1.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 655 Cr (Micro Cap)
205.00
39
0.27%
0.29
0.82%
1.69
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Stock Falls to 52-Week Low of Rs.439.75 Amidst Prolonged Downtrend
Chemfab Alkalis has reached a new 52-week low of Rs.439.75, marking a significant decline in its stock price amid a sustained period of underperformance relative to the broader market and its sector peers.
Read More
Chemfab Alkalis Stock Falls to 52-Week Low of Rs.439.75 Amidst Prolonged Downtrend
Chemfab Alkalis has reached a new 52-week low of Rs.439.75, marking a significant decline in its stock price amid a sustained downward trajectory over recent sessions. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures within the commodity chemicals industry.
Read More
Chemfab Alkalis Stock Falls to 52-Week Low of Rs.445 Amidst Weak Financial Performance
Chemfab Alkalis has touched a new 52-week low of Rs.445, marking a significant decline in its stock price as it continues to trade below all major moving averages amid subdued financial results and market headwinds.
Read More Announcements 
Reg(30)- Change In Name Of The Wholly Owned Subsidiary Of The Company
03-Dec-2025 | Source : BSEIntimation of change in name of the Wholly Owned Subsidiary - CHEMFAB ALKALIS KARAIKAL LIMITED to CHEMFAB KARAIIKAL LIMITED w.e.f. 3rd December 2025.
Announcement under Regulation 30 (LODR)-Acquisition
14-Nov-2025 | Source : BSEIncorporation of Wholly Owned Subsidiary
Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015
11-Nov-2025 | Source : BSESubmission of restated trading plan wrt clarity price action based execution.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.0%)
Dr Rao Holdings Pte Ltd (47.07%)
V. M. Srinivasan (1.81%)
21.61%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -16.36% vs -0.84% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -178.82% vs 127.75% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -1.20% vs -5.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -89.29% vs -57.60% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






